![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2022
Stroh, Jacob; Seckinger, Anja; Heider, Michael; Rudelius, Martina; Eichner, Ruth; Schick, Markus; Slawska, Jolanta; Emde-Rajaratnam, Martina; Salwender, Hans; Bertsch, Uta; Goldschmidt, Hartmut; Weisel, Katja; Scheid, Christof; Keller, Ulrich; Hose, Dirk und Bassermann, Florian
(2022):
MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma.
In: Blood Advances, Bd. 6, Nr. 2: S. 515-520
Paulmann, Carmen; Spallek, Ria; Karpiuk, Oleksandra; Heider, Michael; Schäffer, Isabell; Zecha, Jana; Klaeger, Susan; Walzik, Michaela; Öllinger, Rupert; Engleitner, Thomas; Wirth, Matthias; Keller, Ulrich; Krönke, Jan; Rudelius, Martina; Kossatz, Susanne; Rad, Roland; Kuster, Bernhard und Bassermann, Florian
(2022):
The OTUD6B-LIN28B-MYC axis determines the proliferative state in multiple myeloma.
In: EMBO Journal, Bd. 41, Nr. 20, e110871
2020
Müller‐Thomas, Catharina; Heider, Michael; Piontek, Guido; Schlensog, Martin; Bassermann, Florian; Kirchner, Thomas; Germing, Ulrich; Götze, Katharina S. und Rudelius, Martina
(2020):
Prognostic value of indoleamine 2,3 dioxygenase in patients with higher‐risk myelodysplastic syndromes treated with azacytidine.
In: British Journal of Haematology, Bd. 190, Nr. 3: S. 361-370
[PDF, 6MB]
2016
Eichner, Ruth; Heider, Michael; Fernández-Sáiz, Vanesa; Bebber, Frauke van; Garz, Anne-Kathrin; Lemeer, Simone; Rudelius, Martina; Targosz, Bianca-Sabrina; Jacobs, Laura; Knorn, Anna-Maria; Slawska, Jolanta; Platzbecker, Uwe; Germing, Ulrich; Langer, Christian; Knop, Stefan; Einsele, Herrmann; Peschel, Christian; Haass, Christian 
ORCID: https://orcid.org/0000-0002-4869-1627; Keller, Ulrich; Schmid, Bettina; Götze, Katharina S.; Kuster, Bernhard und Bassermann, Florian
(2016):
Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity.
In: Nature Medicine, Bd. 22, Nr. 7: S. 735-743
ORCID: https://orcid.org/0000-0002-4869-1627; Keller, Ulrich; Schmid, Bettina; Götze, Katharina S.; Kuster, Bernhard und Bassermann, Florian
(2016):
Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity.
In: Nature Medicine, Bd. 22, Nr. 7: S. 735-743